[Form 4] NEXT-ChemX Corporation. Insider Trading Activity
NEXT-ChemX Corporation (CHMX) reported a Form 4 from a director showing termination of two unsigned subscription agreements dated 06/30/2025. The filing states a Subscription Agreement to purchase 10,000 shares of Series A Preferred Stock at $0.001 par (purchase price stated as $10,00 in the filing) and a separate Subscription Agreement to purchase 10,000 shares of Series F Preferred Stock for $10.00 were issued but never signed or executed and were terminated on 06/30/2025. The Form 4 records a disposition code "J" for both classes, with the reporting person showing 0 shares beneficially owned following the reported transactions. Series A Preferred would have carried 500 votes per share and convertible into 250 common shares per preferred if issued; Series F Preferred would have carried 1,000 votes per share and is not convertible, per the explanations in the filing.
NEXT-ChemX Corporation (CHMX) ha riportato un Form 4 da parte di un amministratore che mostra la risoluzione di due accordi di sottoscrizione non firmati datati 30/06/2025. Il deposito indica un accordo di sottoscrizione per l'acquisto di 10.000 azioni di Series A Preferred Stock a valore nominale di 0,001 $ (prezzo di acquisto indicato come 10,00 $ nel documento) e un accordo separato per l'acquisto di 10.000 azioni di Series F Preferred Stock per 10,00 $ che non sono stati firmati né eseguiti e sono stati terminati il 30/06/2025. Il Form 4 riporta un codice di disposizione "J" per entrambe le classi, con la persona riportata che mostra 0 azioni beneficiarie dopo le transazioni segnalate. La Series A Preferred avrebbe diritto a 500 voti per azione ed è convertibile in 250 azioni comuni per azione preferita se emessa; la Series F Preferred avrebbe diritto a 1.000 voti per azione e non è convertibile, secondo le spiegazioni riportate nel documento.
NEXT-ChemX Corporation (CHMX) informó un Form 4 de un director que muestra la terminación de dos acuerdos de suscripción no firmados fechados el 30/06/2025. El archivo indica un Acuerdo de Suscripción para comprar 10,000 acciones de Series A Preferred Stock con valor nominal de $0.001 (el precio de compra indicado como $10,00 en el expediente) y un acuerdo separado para comprar 10,000 acciones de Series F Preferred Stock por $10,00, que no fueron firmados ni ejecutados y se terminaron el 30/06/2025. El Form 4 registra un código de disposición "J" para ambas clases, con la persona informante mostrando 0 acciones beneficiosas tras las transacciones reportadas. Series A Preferred llevaría 500 votos por acción y sería convertible en 250 acciones comunes por acción preferente si se emitiera; Series F Preferred llevaría 1,000 votos por acción y no es convertible, según las explicaciones del expediente.
NEXT-ChemX Corporation (CHMX)는 이사로부터 서명되지 않은 두 개의 구독계약이 2025년 6월 30일에 종료되었음을 보여주는 Form 4를 보고했습니다. 제출 문서는 0.001달러의 액면가를 가진 Series A Preferred Stock 10,000주를 매입하기 위한 구독계약과 10.00달러에 매입하기 위한 별도의 Series F Preferred Stock 10,000주 구독계약이 서명되지 않았고 실행되지 않았으며 2025년 6월 30일에 종료되었다고 명시합니다. Form 4는 두 클래스 모두에 대해 처분 코드 "J"를 기록하고 있으며 보고자(PERSON)가 보고된 거래 이후 보유 이익 주식이 0주로 표시됩니다. Series A Preferred는 주당 500표의 의결권을 가지며 발행될 경우 250주 일반주로 전환 가능하고; Series F Preferred는 주당 1,000표의 의결권을 가지지만 전환은 불가하며, 문서의 설명에 따릅니다.
NEXT-ChemX Corporation (CHMX) a signalé un Form 4 d'un administrateur indiquant la résiliation de deux accords de souscription non signés datés du 30/06/2025. Le dépôt indique un accord de souscription pour l'achat de 10 000 actions de Series A Preferred Stock à une valeur nominale de 0,001 $ (prix d'achat indiqué comme 10,00 $ dans le dossier) et un accord distinct pour l'achat de 10 000 actions de Series F Preferred Stock pour 10,00 $, qui n'ont pas été signés ni exécutés et ont été résiliés le 30/06/2025. Le Form 4 enregistre un code de disposition "J" pour les deux classes, la personne déclarée indiquant posséder 0 actions bénéficiaires après les transactions signalées. La Series A Preferred aurait 500 voix par action et serait convertible en 250 actions ordinaires par action préférentielle si elle était émise; la Series F Preferred aurait 1 000 voix par action et n’est pas convertible, selon les explications du dossier.
NEXT-ChemX Corporation (CHMX) meldete ein Form 4 eines Direktors, das die Beendigung zweier nicht unterzeichneter Abonnementverträge datiert zum 30.06.2025 zeigt. Die Einreichung beschreibt einen Abonnementvertrag zum Kauf von 10.000 Aktien der Series A Preferred Stock mit einer Nennwert von 0,001 $ (Kaufpreis im Nachweis als 10,00 $ angegeben) und einen separaten Abonnementvertrag zum Kauf von 10.000 Aktien der Series F Preferred Stock für 10,00 $, die jedoch nicht unterzeichnet oder ausgeführt wurden und am 30.06.2025 beendet wurden. Das Form 4 verzeichnet einen Veräußerungscode „J“ für beide Klassen, wobei die berichtende Person nach den gemeldeten Transaktionen 0 vorteilhaft gehaltene Aktien aufweist. Die Series A Preferred würde 500 Stimmrechte pro Aktie besitzen und bei Ausgabe in 250 Stammaktien pro Vorzugsaktie umwandelbar sein; Die Series F Preferred würde 1.000 Stimmrechte pro Aktie haben und nicht wandelbar sein, gemäß den Erklärungen im Nachweis.
شركة NEXT-ChemX (CHMX) أبلغت عن نموذج 4 من مدير يظهر إنهاء اتفاقين للاشتراك غير الموقعين بتاريخ 30/06/2025. يذكر الإيداع اتفاق اشتراك لشراء 10,000 سهم من أسهم الفئة A المفضلة بقيمة اسمية 0.001 دولار (سعر الشراء مدرج كـ 10,00 دولار في الملف) واتفاق اشتراك منفصل لشراء 10,000 سهم من أسهم الفئة F المفضلة بمبلغ 10.00 دولار، لكنها لم توقع أو تُنفذ وانتهت في 30/06/2025. يسجل النموذج 4 رمز تصرف "J" لكلا الفئتين، مع ظهور الشخص المبلغ عنهم بملكيتهم 0 أسهم منافعية بعد العمليات المبلغ عنها. ستملك الفئة A المفضلة 500 صوت لكل سهم وتكون قابلة للتحويل إلى 250 سهمًا من الأسهم العادية إذا أصدرت؛ بينما ستملك الفئة F المفضلة 1,000 صوت لكل سهم وليست قابلة للتحويل، وفق الشروحات في الملف.
NEXT-ChemX 公司（CHMX）披露一位董事的 Form 4，显示日期为 2025-06-30 的两份未签署认购协议已终止。 文件称，一份认购协议用于购买 10,000 股 Series A 优先股，面值 0.001 美元（购买价格在文件中显示为 10.00 美元），另一份单独的认购协议用于购买 10,000 股 Series F 优先股，价格为 10.00 美元，但均未签署或执行，且于 2025-06-30 终止。Form 4 记录两类的处置代码为「J」，报告人报告交易后受益所有权为 0 股。若 Series A 优先股发行，每股将拥有 500 票表决权，若发行则可转换为每股 250 股普通股；Series F 优先股每股有 1,000 票表决权，但不可转换，以上均以文件中的说明为准。
- No new beneficial ownership recorded following termination of the subscription agreements, meaning no immediate dilution from these specific proposed issuances
- Clear disclosure of material terms for the proposed Series A and Series F preferred shares (voting and conversion mechanics) even though the agreements were not executed
- Proposed preferred issuances were terminated, indicating the intended subscription transactions did not complete
- Filing contains a typographical or formatting error in the stated purchase price for Series A (listed as "$10,00") which may require clarification
Insights
TL;DR: Two unsigned subscription agreements were terminated; no new preferred ownership resulted and reported beneficial ownership is zero.
The filing documents that subscription agreements for 10,000 Series A and 10,000 Series F preferred shares were issued but never executed and were terminated on 06/30/2025, triggering disposition code "J." Material governance features are disclosed: Series A would have had 500 votes per share and convertibility into 250 common shares per preferred; Series F would have had 1,000 votes per share and is non-convertible. Because the agreements were not executed and were terminated, the reporting person holds zero beneficial shares following the events. This is a routine disclosure of canceled capitalization arrangements rather than an executed transfer of securities.
TL;DR: Termination of proposed preferred issuances means no dilution or change in voting power occurred from these agreements.
The Form 4 shows no completed purchases: transaction code "J" reflects termination of the subscription agreements dated 06/30/2025. The filing explicitly states resulting beneficial ownership is zero for both Series A and Series F preferred classes. The explanatory notes quantify potential voting and conversion terms had the Series A been issued and converted, but those terms did not become effective because the agreements were not executed. From a securities perspective, this filing documents an aborted financing or allocation rather than a material capital change.
NEXT-ChemX Corporation (CHMX) ha riportato un Form 4 da parte di un amministratore che mostra la risoluzione di due accordi di sottoscrizione non firmati datati 30/06/2025. Il deposito indica un accordo di sottoscrizione per l'acquisto di 10.000 azioni di Series A Preferred Stock a valore nominale di 0,001 $ (prezzo di acquisto indicato come 10,00 $ nel documento) e un accordo separato per l'acquisto di 10.000 azioni di Series F Preferred Stock per 10,00 $ che non sono stati firmati né eseguiti e sono stati terminati il 30/06/2025. Il Form 4 riporta un codice di disposizione "J" per entrambe le classi, con la persona riportata che mostra 0 azioni beneficiarie dopo le transazioni segnalate. La Series A Preferred avrebbe diritto a 500 voti per azione ed è convertibile in 250 azioni comuni per azione preferita se emessa; la Series F Preferred avrebbe diritto a 1.000 voti per azione e non è convertibile, secondo le spiegazioni riportate nel documento.
NEXT-ChemX Corporation (CHMX) informó un Form 4 de un director que muestra la terminación de dos acuerdos de suscripción no firmados fechados el 30/06/2025. El archivo indica un Acuerdo de Suscripción para comprar 10,000 acciones de Series A Preferred Stock con valor nominal de $0.001 (el precio de compra indicado como $10,00 en el expediente) y un acuerdo separado para comprar 10,000 acciones de Series F Preferred Stock por $10,00, que no fueron firmados ni ejecutados y se terminaron el 30/06/2025. El Form 4 registra un código de disposición "J" para ambas clases, con la persona informante mostrando 0 acciones beneficiosas tras las transacciones reportadas. Series A Preferred llevaría 500 votos por acción y sería convertible en 250 acciones comunes por acción preferente si se emitiera; Series F Preferred llevaría 1,000 votos por acción y no es convertible, según las explicaciones del expediente.
NEXT-ChemX Corporation (CHMX)는 이사로부터 서명되지 않은 두 개의 구독계약이 2025년 6월 30일에 종료되었음을 보여주는 Form 4를 보고했습니다. 제출 문서는 0.001달러의 액면가를 가진 Series A Preferred Stock 10,000주를 매입하기 위한 구독계약과 10.00달러에 매입하기 위한 별도의 Series F Preferred Stock 10,000주 구독계약이 서명되지 않았고 실행되지 않았으며 2025년 6월 30일에 종료되었다고 명시합니다. Form 4는 두 클래스 모두에 대해 처분 코드 "J"를 기록하고 있으며 보고자(PERSON)가 보고된 거래 이후 보유 이익 주식이 0주로 표시됩니다. Series A Preferred는 주당 500표의 의결권을 가지며 발행될 경우 250주 일반주로 전환 가능하고; Series F Preferred는 주당 1,000표의 의결권을 가지지만 전환은 불가하며, 문서의 설명에 따릅니다.
NEXT-ChemX Corporation (CHMX) a signalé un Form 4 d'un administrateur indiquant la résiliation de deux accords de souscription non signés datés du 30/06/2025. Le dépôt indique un accord de souscription pour l'achat de 10 000 actions de Series A Preferred Stock à une valeur nominale de 0,001 $ (prix d'achat indiqué comme 10,00 $ dans le dossier) et un accord distinct pour l'achat de 10 000 actions de Series F Preferred Stock pour 10,00 $, qui n'ont pas été signés ni exécutés et ont été résiliés le 30/06/2025. Le Form 4 enregistre un code de disposition "J" pour les deux classes, la personne déclarée indiquant posséder 0 actions bénéficiaires après les transactions signalées. La Series A Preferred aurait 500 voix par action et serait convertible en 250 actions ordinaires par action préférentielle si elle était émise; la Series F Preferred aurait 1 000 voix par action et n’est pas convertible, selon les explications du dossier.
NEXT-ChemX Corporation (CHMX) meldete ein Form 4 eines Direktors, das die Beendigung zweier nicht unterzeichneter Abonnementverträge datiert zum 30.06.2025 zeigt. Die Einreichung beschreibt einen Abonnementvertrag zum Kauf von 10.000 Aktien der Series A Preferred Stock mit einer Nennwert von 0,001 $ (Kaufpreis im Nachweis als 10,00 $ angegeben) und einen separaten Abonnementvertrag zum Kauf von 10.000 Aktien der Series F Preferred Stock für 10,00 $, die jedoch nicht unterzeichnet oder ausgeführt wurden und am 30.06.2025 beendet wurden. Das Form 4 verzeichnet einen Veräußerungscode „J“ für beide Klassen, wobei die berichtende Person nach den gemeldeten Transaktionen 0 vorteilhaft gehaltene Aktien aufweist. Die Series A Preferred würde 500 Stimmrechte pro Aktie besitzen und bei Ausgabe in 250 Stammaktien pro Vorzugsaktie umwandelbar sein; Die Series F Preferred würde 1.000 Stimmrechte pro Aktie haben und nicht wandelbar sein, gemäß den Erklärungen im Nachweis.
FAQ
What did the Form 4 filed for CHMX report on 06/30/2025?
Did the reporting person acquire Series A or Series F preferred shares in NEXT-ChemX?
What were the stated voting and conversion terms for the proposed Series A preferred?
What voting rights were disclosed for Series F preferred in the filing?
What does transaction code 'J' mean in this Form 4?
